Search hospitals > Colorado > Denver

Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

Claim this profile
Denver, Colorado 80218
Global Leader in Tumors
Global Leader in Leukemia
Conducts research for Lymphoma
Conducts research for Recurrence
Conducts research for Neuroblastoma
110 reported clinical trials
1 medical researcher
Photo of Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center in DenverPhoto of Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center in DenverPhoto of Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center in Denver

Summary

Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Tumors, Leukemia, Lymphoma, Recurrence, Neuroblastoma and other specialties. Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center is involved with conducting 110 clinical trials across 269 conditions. There are 1 research doctors associated with this hospital, such as Jennifer J. Clark.

Area of expertise

1Tumors
Global Leader
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center has run 35 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage I
Stage II
2Leukemia
Global Leader
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center has run 31 trials for Leukemia. Some of their research focus areas include:
Stage II
NTRK1 positive
NTRK positive

Top PIs

Clinical Trials running at Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

Rhabdomyosarcoma
Osteosarcoma
Langerhans Cell Histiocytosis
Germ Cell Tumors
Non-Hodgkin's Lymphoma
Brain Tumor
Leukemia
Acute Lymphoblastic Leukemia
Neuroectodermal Tumors
Rhabdoid Tumor
Image of trial facility.

Combination Chemotherapy

for Rhabdomyosarcoma

This study is evaluating whether a combination of chemotherapy drugs is more effective than a single chemotherapy drug for treating rhabdomyosarcoma.
Recruiting2 awards Phase 35 criteria
Image of trial facility.

Chemotherapy

for Rhabdomyosarcoma

Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma. Another aim of the study it to find out how well patients with low risk rhabdomyosarcoma (LR-RMS) respond to standard chemotherapy when patients with VLR-RMS and patients who have rhabdomyosarcoma with DNA mutations get separate treatment. Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
Recruiting2 awards Phase 3
Image of trial facility.

Genetic Testing-Directed Therapy

for Pediatric Cancer

This study is evaluating whether genetic testing may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center?
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Tumors, Leukemia, Lymphoma, Recurrence, Neuroblastoma and other specialties. Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center is involved with conducting 110 clinical trials across 269 conditions. There are 1 research doctors associated with this hospital, such as Jennifer J. Clark.